DIN 58902:2000-03

The document is applicable to determination of batroxobin time in plasma from citrated venous blood. Most fibrin polymerisation disorders increase the batroxobin time. Batroxobin time is not effected by heparin, heparinoids or hirudin. It is therefore used to determine the inhibiting effect of fibrin degradation products as well as detect hypofibrinogenaemias and dysfibrinogenaemias. Futhermore, the batroxobin time may be used to determine whether heparin has an effect on the thrombin time.